TECH Share Price

Open 107.69 Change Price %
High 107.75 1 Day -1.66 -1.53
Low 105.30 1 Week 0.72 0.68
Close 106.59 1 Month 5.84 5.80
Volume 210219 1 Year 14.65 15.93
52 Week High 117.42
52 Week Low 79.95
TECH Important Levels
Resistance 2 108.86
Resistance 1 107.93
Pivot 106.55
Support 1 105.25
Support 2 104.32
NASDAQ USA Most Active Stocks
FNFG 10.18 -0.20%
DELL 13.86 0.22%
RFMD 16.59 -2.07%
RIMM 13.03 0.39%
BBEP 0.12 0.00%
GTAT 0.44 0.00%
SUSQ 14.20 -0.77%
MU 20.45 7.29%
MU 20.45 7.29%
MU 20.45 7.29%
More..
NASDAQ USA Top Gainers Stocks
LOCM 0.09 50.00%
ANTH 2.03 38.10%
EMKR 8.45 31.01%
MBLX 0.32 28.00%
BSDM 0.62 26.53%
SNTA 0.34 25.93%
OTT 2.39 25.13%
HTCO 8.00 23.08%
ATEA 1.95 21.88%
ATEA 1.95 21.88%
More..
NASDAQ USA Top Losers Stocks
TXCC 0.01 -95.00%
HCIIP 10.10 -67.52%
CRMB 0.27 -57.81%
KIOR 0.03 -57.14%
OSH 0.26 -49.02%
OSH 0.26 -49.02%
DVOX 0.05 -44.44%
PRXI 0.21 -43.24%
TRGT 0.96 -41.46%
QKLS 0.12 -36.84%
More..

Techne Corporation (NASDAQ: TECH)

TECH Technical Analysis 3
As on 7th Dec 2016 TECH Share Price closed @ 106.59 and we RECOMMEND Buy for LONG-TERM with Stoploss of 101.47 & Buy for SHORT-TERM with Stoploss of 105.79 we also expect STOCK to react on Following IMPORTANT LEVELS.
TECH Target for December
1st Target up-side 110.66
2nd Target up-side 114.34
3rd Target up-side 118.02
1st Target down-side 100.16
2nd Target down-side 96.48
3rd Target down-side 92.8
TECH Other Details
Segment EQ
Market Capital 2603798528.00
Sector Healthcare
Industry Biotechnology
Offical website http://www.techne-corp.com
TECH Address
TECH
614 McKinley Place North East
Minneapolis, MN 55413-2610
United States
Phone: 612-379-8854
Fax: 612-379-6580
Interactive Technical Analysis Chart Techne Corporation ( TECH NASDAQ USA )
Java support must be enabled in order to display FnCharts.
You can download Java from http://www.java.com
Your Comments and Response on Techne Corporation
TECH Business Profile
TECHNE Corporation is engaged in the development, manufacture and sale of biotechnology products and hematology calibrators and controls. These activities are conducted through its wholly owned subsidiaries, Research and Diagnostic Systems, Inc. (R&D Systems), Boston Biochem, Inc. (Boston Biochem), and BiosPacific, Inc. (BiosPacific). The Company operates in two segments: biotechnology and hematology. The Company's biotechnology reporting segment develops, manufactures and sells biotechnology research and diagnostic products world-wide. The Company's hematology reporting segment, which consists of R&D Systems' Hematology Division, develops and manufactures hematology controls and calibrators for sale worldwide. In July 2013, the Company announced that it has completed the acquisition of Bionostics Holdings Limited and its operating subsidiary Bionostics, Inc. (Bionostics).